News About M&A/IPOs

 

Belgian psychiatry provider enters Netherlands

Belgian psychiatry operator Reseau Abilis has acquired a small Dutch provider, putting it in direct competition with Orpea's Woonzorgnet. We speak to a Dutch specialist about the sector and hear their thoughts on how to build a successful psychiatric business.

Fleury acquires Diagmax Group

Brazil's second-largest lab and imaging group Fleury has added six sites to its portfolio through the acquisition of local imaging group Diagmax Group.

HM Hospitales to sell two hospitals

HM Hospitales, the second largest hospital chain in Spain is selling two Madrid hospitals. We look at the value and the significance for the Spanish health care property market.

Ameos HY results show competitive growth

German PE-backed psychiatry specialist Ameos has made a number of small acquisitions this year which have contributed to competitive growth rates for the company. Ameos has the largest focus on psychiatry and mental health among German hospital groups, with revenues in the sector at €426m in 2018, over half of total turnover. 

Orpea enters the UK with acquisition in psychiatry

Pan-European nursing home and psychiatric giant Orpea has entered the UK market for the first time. The group has bought a French psychiatric specialist which owns a premium facility in London. HBI speaks to Orpea and a market adviser about strategy, multiples, and whether this opens the door to further activity in the UK.

France’s third largest lab group ‘for sale’

One of France's largest lab groups, Inovie, has appointed France-based international bank BNP Paribas to explore potential financing - but its complex shareholder structure and president's public objection to external investment leaves open questions about how any sale could work.

Penta courts investors

HBI can exclusively reveal that Penta has started meeting with investors with a view to selling at least a minority stake, months after it denied the company was for sale. It tells HBI that it wants a partner who can support international expansion plans.

Spire divests oncology centres to GenesisCare

Spire has sold its two oncology centres to specialist provider GenesisCare, while together they have entered into a JV to deliver oncology services at one of Spire's hospitals. Its CEO suggests a further divestment is on the cards. 

Althea and Medipass may sell as TPM equipment sector hots up

Althea, by far the largest player in the third party managed equipment market in EMEA has been put up for sale by Permira, as first reported here in 2018. Meanwhile, we hear listed Italian player KOS is pondering the sale of Medipass.

MedLife makes first foray onto oncology market

Listed Romanian healthcare group MedLife has entered the oncology market for the first time, acquiring a majority stake in a Bucharest provider. We speak to a market expert about the move.

IHH buys hospital from major shareholder

Pan-Asian hospital group IHH Healthcare Berhad is further consolidating its strong position in Malaysia with the acquisition of a substantial private medical centre in its capital, Kuala Lumpur.

French lab group seeks €400-500m sale

The owners of France's sixth biggest lab group Laborizon are reportedly selling a majority stake in the company, we hear, with first-round bids due Friday, September 27.

What are Germany’s biggest for-profit healthcare markets?

Germany spends more on healthcare in real terms than any country in Europe. Alongside France, it also has the highest spending ratio for healthcare at 11.2% GDP. Here, we show you how the German for-profit healthcare market breaks down by sector and give you some insight into M&A in its three biggest markets.

Big hospital deals in Asia close to completion

A deal to buy pan-southeast Asian hospital group Columbia Asia has reportedly been agreed, while The Philippines' largest private hospital group's dual-track process is rolling on with a prospectus filed and second-round bids in.

Hirslanden offloads hospital to rival

Mediclinic-owned Swiss hospital group Hirslanden is selling a small hospital to rival Swiss Medical Network (SMN) in an opco-propco deal. We are told that most of the transaction value is in the real estate.

Affidea pulls Portuguese lab sales process

Pan-European imaging and outpatient group Affidea kicked off a process to sell its Portuguese lab business in 2018 but may have opted to retain it, HBI understands.
+00 44 207 183 3779
+00 44 207 183 3779

Find Us